Updated on 6 October 2026
RADIOPATH: Radiology-Pathology matching mold
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy
About
State of the art & Medical Need
The use of radiological imaging to extract quantitative features for the noninvasive characterization of tumors is gaining increased attention, yet whole histopathological analysis based on tissue biopsy or surgical resection remains the diagnostic gold standard. To validate radiologic features and ensure reliable correlation between imaging and tissue-based observations, accurate spatial alignment between radiologic and histologic data is essential. In this context, 3D printing has emerged as a transformative technology that supports clinicians by enabling the production of cost-effective, patient-specific medical devices that can aid in specimen analysis.
Solution
RADIOPATH (Radiology-Pathology matching mold) is a patient-specific 3D-printed system that ensures accurate alignment between radiological imaging and histopathological analysis. Created from pre-surgical scans and image segmentation, it features a dedicated mold and cutting guides to preserve specimen orientation and ensure radiological–histological correlation. This consistency improves reproducibility and enhances diagnostic confidence.
Advantages
- Patient-specific 3D-printed mold
- Accurate positioning of the pathological specimen
- Standardization of gross cutting procedures
- Adaptability to different solid tumors
- Compatibility with radiological imaging scanners
- Possibility of pathological specimen fixation directly inside the mold
- Possibility of radiological-histological correlation
IP asset
Patent application IT102025000026158; co-owned by IEO, Politecnico of Milan and University of Milan
Stage
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Attached files
Organisation
Istituto Europeo di Oncologia (IEO)
Hospital & healthcare organization / Public health agency
Milan, Italy
Similar opportunities
Project cooperation
Healthcare IT Solutions to enable interoperability based on HL7 standard and IHE framework
Renato Calamai
Administrator at eHealthTech s.r.l.
Firenze, Italy
Investment
PETsign - A PET-surrogate multigene signature for breast cancer prognosis
- Pre-seed funding | Idea validation
- Seed funding | Get business started
Giorgia Moschetti
IP & Technology Transfer Specialist at Istituto Europeo di Oncologia (IEO)
Milan, Italy
Product
Prosthetic device for temporomandibular joint and corresponding prosthetic assembly
- License partner
Enrico Pusceddu
Technology Transfer manager at Università degli Studi di Udine
Udine, Italy